Documento de Recomendaciones de la Sociedad Española de Reumatología para el manejo clínico del paciente con artritis reumatoide que no puede utilizar metotrexato

García-Vicuña, Rosario; Martín-Martínez, María Auxiliadora; Gonzalez-Crespo, María Rosa; Tornero-Molina, Jesús; Fernández-Nebro, Antonio; Blanco-García, Francisco Javier; Blanco-Alonso, Ricardo; Marsal-Barril, Sara.
Reumatol. clín. (Barc.) ; 13(3): 127-138, mayo-jun. 2017. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-162467

Documentos relacionados

  1. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
  2. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.
  3. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
  4. Rheumatoid arthritis.
  5. Development of Methotrexate Complexes Endowed with New Biological Properties Envisioned for Musculoskeletal Regeneration in Rheumatoid Arthritis Environments.
  6. Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
  7. What do patients on methotrexate need and expect at the clinic? An online patient survey.
  8. [Re-recognition of methotrexate monotherapy in rheumatoid arthritis].
  9. [Expert recommendations for the chronic disease management of rheumatic arthritis].
  10. Treating rheumatoid arthritis.